Daxor Corporation

US$8.45As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DXRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 0.50%
Div yield —
ROE 14.24%
Medical Instruments & Supplies
Beta (5Y) 0.44
PE TTM 7.920
TSR TTM (36.61%)
Mkt cap US$49.33M
ROIC (3.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.45
(0.02%)
(36.66%)
Hold 9|4|3|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.15
0.15
0.15
0.17
37.24%
30.28%
15.08%
14.82%
Revenue$M
5.350
5.223
5.505
5.481
9.07%
6.21%
6.09%
3.17%
Peers (US$49.33M)
Cap (US$)
PE
30.30M
15.70x
50.96M
9.188x
Capital
TTM
5Y
10Y
Leveragex
0.235
0.091
0.083
EBIT/Intx
1.499
0.169
0.162
Own earn%
(295.48)
(153.69)
(141.11)
Sh yield%
42.13
43.82
43.96
Owners
Insiders/Inst%
2.72
76.79
Short interest%
1.73
SBC / revenue%
0.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
16–23
$1 testx
−0.3
Incr. ROIC%
14